Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FRDH6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $85,243
Award facts
- Contract value 100% obligated
- $85,243.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $85,243.20 to DMS Pharmaceutical Group Inc. for Nexplanon 68 mg implants, with an ultimate completion date of December 17, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, is supplying this contraceptive implant product to support Department of Defense medical supply requirements. The delivery order was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. No subcontractors have been identified on this award.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA designated as SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling and completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors to supply comprehensive pharmaceutical products and medical consumables to military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous delivery orders across diverse therapeutic categories positions the company as a critical pharmaceutical supplier within the Department of Defense's global medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FRDH6?
SPE2DR26FRDH6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FRDH6 worth?
The government has obligated $85,243 on SPE2DR26FRDH6.
Is contract SPE2DR26FRDH6 an order under another contract?
Yes. SPE2DR26FRDH6 is a delivery order under SPE2DR25D9143, an indefinite delivery contract.
Was contract SPE2DR26FRDH6 competed?
The extent of competition for SPE2DR26FRDH6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award